The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: Relevance to progression of the disease

Journal of Neurochemistry

Volumn 109, Issue 2, 2009, Pages 656-669

  Joglar, Belen ^a   Rodriguez Pallares, Jannette ^a   Rodriguez Perez, Ana Isabel ^a   Rey, Pablo ^a   Guerra, Maria Jose ^a   Labandeira Garcia, Jose Luis ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Angiotensin; Microglia; NADPH oxidase; Neurodegeneration; Oxidative stress; Parkinson

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; DOPAMINE; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEGENERATION; BRAIN PROTECTION; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; ENZYME ACTIVATION; INFLAMMATION; MESENCEPHALON; MICROGLIA; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; TISSUE CULTURE;

ANGIOTENSINS; ANIMALS; BRAIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; PARKINSON DISEASE, SECONDARY; RATS;

MUS;

EID: 62649089147     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.05999.x     Document Type: Article

References (45)

1. Allen A. M., MacGregor D. P., Chai S. Y., Donnan G. A., Kaczymarzyk S., Richardson K., Kalnins R., Ireton J. Mendelsohn F. A. O. (1992) Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Ann. Neurol. 32, 339 344.
2. Babior B. M. (1999) NADPH oxidase: an update. Blood 93, 1464 1476.
3. Babior B. M. (2004) NADPH oxidase. Curr. Opin. Immunol. 16, 42 47.
4. Bek M. J., Wang X., Asico L. D. et al. (2006) Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension 47, 288 295.
5. Biber K., Neumann H., Inoue K. Boddeke H. W. (2007) Neuronal 'On' and 'Off' signals control microglia. Trends Neurosci. 30, 596 602.
6. Block M. L. Hong J. S. (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76, 77 98.
7. Block M. L., Li G., Qin L., Wu X., Pei Z., Wang T., Wilson B., Yang J. Hong J. S. (2006) Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J. 20, 251 258.
8. Brown D. C., Steward L. J., Ge J. Barnes N. M. (1996) Ability of angiotensin II to modulate striatal dopamine release via AT1 receptor in vitro and in vivo. Br. J. Pharmacol. 18, 414 420.
9. Cai H., Griendling K. K. Harrison D. G. (2003) The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24, 471 478.
10. Ferrari R., Guardigli G., Cicchitelli G., Valgimigli M., Merli E., Soukhomorskaia O. Ceconi C. (2002) Angiotensin II overproduction: enemy of the vessel wall. Eur. Heart J. 4 (Suppl. A A26 A30.
11. Gao H. M., Liu B., Zhang W. Hong J. S. (2003a) Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J. 17, 1954 1956.
12. Gao H. M., Liu B., Zhang W. Hong J. S. (2003b) Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. FASEB J. 17, 1957 1959.
13. Grammatopoulos T. N., Jones S. M., Ahmadi F. A., Hoover B. R., Snell L. D., Skoch J., Jhaveri V. V., Poczobutt A. M., Weyhenmeyer J. A. Zawada W. M. (2007) Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra. Mol. Neurodegener. 2, 1.
14. Griendling K. K., Minieri C. A., Ollerenshaw J. D. Alexander R. W. (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141 1148.
15. Hébert G., Arsaut J., Dantzer R. Demotes-Mainard J. (2003) Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin. Neurosci. Lett. 349, 191 195.
16. Hemming M. L., Selkoe D. J. Farris W. (2007) Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid β-protein metabolism in mouse models of Alzheimer disease. Neurobiol. Dis. 26, 273 281.
17. Hong H., Zeng J. S., Kreulen D. L., Kaufman D. I. Chen A. F. (2006) Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke. Am. J. Physiol. Heart Circ. Physiol. 291, H2210 H2215.
18. +) in brain tissue homogenates. J. Neurosci. Methods 137, 221 226.
19. Hussain T., Abdul Wahab R., Kotak D. K. Lokhandwala M. F. (1998) Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules. Hypertension 32, 1054 1059.
20. Jackson-Lewis V., Jakowec M., Burke R. E. Przedborski S. (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4, 257 269.
21. Jones S. A., Hancock J. T., Jones O. T., Neubauer A. Topley N. (1995) The expression of NADPH oxidase components in human glomerular mesangial cells, detection of protein and mRNA for p47phox, p67phox, and p22phox. J. Am. Soc. Nephrol. 5, 1483 1491.
22. Liberatore G. T., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M., McAuliffe W. G., Dawson V. L., Dawson T. M. Przedborski S. (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5, 1403 1409.
23. McKinley M. J., Albiston A. L., Allen A. M., Mathai M. L., May C. N., McAllen R. M., Oldfield B. J., Mendelsohn F. A. O. Chai S. (2003) The brain renin-angiotensin system, location and physiological roles. Int. J. Biochem. Cell Biol. 35, 901 918.
24. Mendelsohn F. A. O., Jenkins T. A. Berkovic S. F. (1993) Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rat. Brain Res. 613, 221 229.
25. Min K. J., Yang M. S., Kim S. U., Jou I. Joe E. H. (2006) Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J. Neurosci. 26, 1880 1887.
26. Muñoz A., Rey P., Guerra M. J., Mendez-Alvarez E., Soto-Otero R. Labandeira-Garcia J. L. (2006) Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Neuropharmacology 51, 112 120.
27. Münzel T. Keany J. F. (2001) Are ACE inhibitors a "magic bullet" against oxidative stress? Circulation 104, 1571 1577.
28. Neumann H. (2001) Control of glial immune function by neurons. Glia 36, 191 199.
29. Noda M., Kariura Y., Pannasch U. et al. (2007) Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J. Neurochem. 101, 397 410.
30. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L. Dawson T. M. (1996) Role of neuronal nitric oxide in 1-methyl-4phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl Acad. Sci. USA 93, 4565 4571.
31. Przedborski S., Jackson-Lewis V., Djaldetti R., Liberatore G., Vila M., Slovodanka V. Almer G. (2000) The parkinsonian toxin MPTP: action and mechanism. Rest. Neurol. Neurosci. 16, 135 142.
32. Qin L., Liu Y., Wang T., Wei S. J., Block M. L., Wilson B., Liu B. Hong J. S. (2004) NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 279, 1415 1421.
33. Rodriguez-Pallares J., Quiroz C. R., Parga J. A., Guerra M. J. Labandeira-Garcia J. L. (2004) Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors. Eur. J. Neurosci. 20, 1489 1498.
34. Rueckschloss U., Quinn M. T., Holtz J. Morawietz H. (2002) Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 22, 1845 1851.
35. Saavedra J. M. (2005) Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell. Mol. Neurobiol. 25, 485 512.
36. Seshiah P. N., Weber D. S., Rocic P., Valppu L., Taniyama Y. Griendling K. K. (2002) Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res. 91, 406 413.
37. Suzuki Y., Ruiz-Ortega M., Lorenzo O., Ruperez M., Esteban V. Egido J. (2003) Inflammation and angiotensin II. Int. J. Biochem. Cell Biol. 35, 881 900.
38. Touyz R. M., Chen X., Tabet F., Yao G., He G., Quinn M. T., Pagano P. J. Schiffrin E. L. (2002) Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries, regulation by angiotensin II. Circ. Res. 14, 1205 1213.
39. Wang G., Anrather J., Huang J., Speth R. C., Pickel V. Iadecola C. (2004) NADPH oxidase contributes to angiotensin II signalling in the nucleus tractus solitarius. J. Neurosci. 24, 5516 5524.
40. 2+, and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension 48, 482 489.
41. Wu D. C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D. K., Ischiropoulos H. Przedborski S. (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 1763 1771.
42. Wu D., Teisman P., Tieu K., Vila M., Jackson-Lewis V., Ischiropoulos H. Przedborski S. (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc. Natl Acad. Sci. USA 100, 6145 6150.
43. Zalba G., San Jose G., Moreno M. U., Fortuño M. A., Fortuño A., Beaumont F. J. Diez J. (2001) Oxidative stress in arterial hypertension. Role of NADPH oxidase. Hypertension 38, 1395 1399.
44. Zeng C., Liu Y., Wang Z. et al. (2006) Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ. Res. 99, 494 500.
45. Zhao C., Ling Z., Newman M. B., Bhatia A. Carvey P. M. (2007) TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol. Dis. 26, 36 46.